durvalumab,tremelimumab
astrazeneca,pfizer
['duthy ']
 the #duthy research suggests that the combination of 2 immunotherapies significantly boosts the survival of patients with refractory advanced thyroid cancer, a population that is often excluded from treatment and with limited life expectancy
Leading translational research to accelerate & advance personalized and targeted therapies against cancer. 
@iCERCA centre